The impact of COVID ‐19 pandemic on the management of patients with chronic urticaria: An observational two‐center study from Turkey-Reference-Cited by-同舟云学术

The impact of COVID ‐19 pandemic on the management of patients with chronic urticaria: An observational two‐center study from Turkey

Published:2020-12-19 Issue:1 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Erdem Yasemin¹^ORCID,Polat Ekinci Algün²^ORCID,Altunay Ilknur Kivanc¹^ORCID,Sivaz Onur¹^ORCID,Inal Sena¹^ORCID,Gokalp Mehmet Onur²^ORCID,Pehlivan Gizem²^ORCID,Özkaya Esen²^ORCID

Affiliation:

1. Sisli Hamidiye Etfal Training and Research Hospital, Department of Dermatology Health Science University Istanbul Turkey

2. Istanbul Faculty of Medicine, Department of Dermatology and Venereology Istanbul University Istanbul Turkey

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14652

Reference34 articles.

1. WHO(2020) Considerations in adjusting public health and social measures in the context of COVID‐19 (Interim Guidance 16 April 2020) (WHO 2020).https://www.who.int/publications-detail/considerations-in-adjusting-public-health-andsocial-measures-in-the-context-of-covid-19-interim-guidance. Accessed November 4 2020.

2. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

3. The diagnosis and management of acute and chronic urticaria: 2014 update

4. Doxepin in difficult‐to‐treat chronic urticaria: A retrospective, cross‐sectional study from Turkey

5. Management of Allergic Patients During the COVID-19 Pandemic in Asia

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment;Anais Brasileiros de Dermatologia;2023-03

2. The effect of COVID-19 on patients recieving omalizumab treatment;Revue Française d'Allergologie;2023-03

3. Treatment Adherence in Dermatology During the COVID-19 Pandemic: A Review;Cureus;2023-01-24

4. A scoping review of non-professional medication practices and medication safety outcomes during public health emergencies;Public Health;2023-01

5. Safely use of omalizumab during SARS‐CoV ‐2 infection in patients with chronic spontaneous urticaria;Journal of Cosmetic Dermatology;2022-11-30